Home › Exosome Diagnostics Completes $30 Million Series C Financing

Exosome Diagnostics Completes $30 Million Series C Financing

Jul 24, 2017

NEW YORK (GenomeWeb) – Exosome Diagnostics said today that it has closed a $30 million Series C financing, led by Tiger Partners and Forbion Capital Partners.

Other participants included Blue Ridge Capital, NGN Capital, Arcus Ventures, b-to-v Partners, and CD Ventures among others.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

What's Popular?

In Business News

  1. Thermo Fisher Scientific Gets CE-IVD Mark for NGS Cancer Test

  2. Foundation Medicine, Novartis Partner to Develop CDx for Oncology Drugs

  3. Exact Sciences Acquires Sample Preservation Technology Provider Biomatrica

  4. Singlera Genomics Presents Data on Cell-Free DNA Methylation Test for Early Cancer Detection

    Premium

  5. Roche Diagnostics' Revenues Grow 6 Percent in First Nine Months of 2018

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.